X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (283) 283
index medicus (189) 189
male (169) 169
neurotoxicity (162) 162
rats (139) 139
toxicology (131) 131
brain (109) 109
neurotoxicity syndromes - enzymology (109) 109
humans (102) 102
neurotoxicity syndromes - etiology (93) 93
pharmacology & pharmacy (92) 92
neurosciences (89) 89
mice (87) 87
oxidative stress (84) 84
brain - enzymology (74) 74
brain - drug effects (70) 70
female (70) 70
rats, wistar (63) 63
toxicity (63) 63
neurons (59) 59
dose-response relationship, drug (57) 57
neurons - drug effects (53) 53
neurotoxicity syndromes - pathology (53) 53
rats, sprague-dawley (52) 52
neurons - enzymology (51) 51
apoptosis (50) 50
enzymes (48) 48
neurotoxicity syndromes - prevention & control (48) 48
analysis (47) 47
neurotoxicity syndromes - metabolism (45) 45
acetylcholinesterase - metabolism (44) 44
disease models, animal (43) 43
rodents (43) 43
oxidative stress - drug effects (41) 41
proteins (41) 41
biochemistry & molecular biology (40) 40
inhibition (40) 40
time factors (38) 38
alzheimers-disease (37) 37
behavior, animal - drug effects (37) 37
acetylcholinesterase (36) 36
cells, cultured (34) 34
neurodegeneration (33) 33
neurology (31) 31
research article (31) 31
medicine (30) 30
neuroprotective agents - pharmacology (30) 30
cell biology (29) 29
neurons - pathology (29) 29
neurotoxicity syndromes - physiopathology (29) 29
exposure (28) 28
physiological aspects (28) 28
antioxidants (27) 27
hippocampus - drug effects (27) 27
neurotoxicity syndromes - genetics (27) 27
parkinson's disease (26) 26
parkinsons-disease (26) 26
apoptosis - drug effects (25) 25
mice, inbred c57bl (25) 25
neuroprotection (25) 25
cell survival - drug effects (24) 24
lipid peroxidation - drug effects (24) 24
neurotoxicity syndromes - drug therapy (24) 24
brain - pathology (23) 23
cholinesterase inhibitors - toxicity (23) 23
hippocampus - enzymology (23) 23
multidisciplinary sciences (23) 23
neurodegenerative diseases (23) 23
neurotoxicity syndromes - psychology (23) 23
organophosphorus compounds (23) 23
science (23) 23
biochemistry (22) 22
in-vitro (22) 22
phosphorylation (22) 22
research (22) 22
health aspects (21) 21
metabolism (21) 21
rat-brain (21) 21
reactive oxygen species - metabolism (21) 21
brain - metabolism (20) 20
cell line, tumor (20) 20
motor activity - drug effects (20) 20
neurons - metabolism (20) 20
activation (19) 19
animals, newborn (19) 19
dopamine (19) 19
immunohistochemistry (19) 19
nerve tissue proteins - metabolism (19) 19
neuropathy target esterase (19) 19
neuroprotective agents - therapeutic use (19) 19
rat (19) 19
signal transduction - drug effects (19) 19
dopamine - metabolism (18) 18
expression (18) 18
hippocampus (18) 18
insecticides - toxicity (18) 18
lipid-peroxidation (18) 18
nervous system (18) 18
biology (17) 17
chlorpyrifos (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 04/2011, Volume 472, Issue 7343, pp. 319 - 324
Journal Article
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 10/2016, Volume 36, Issue 5, pp. 513 - 517
Here, we investigated the possible role of the Nicotinamide Adenine Dinucleotide Phosphate oxidase NOX2-derived brain oxidative stress in a fatal case of... 
excited delirium | Key Words cocaine | NADPH oxidase | oxidative stress | Delirium - enzymology | NADPH Oxidases | Neurotoxicity Syndromes - enzymology | Oxidative Stress | Cocaine - toxicity | Humans | Fatal Outcome | Adult | Male | Membrane Glycoproteins | NADPH Oxidase 2 | Delirium - chemically induced | Index Medicus
Journal Article
CNS Drugs, ISSN 1172-7047, 2/2014, Volume 28, Issue 2, pp. 131 - 145
Antiretroviral drugs are associated with a variety of adverse effects on the central and peripheral nervous systems. The frequency and severity of... 
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | EFAVIRENZ DOSE REDUCTION | PSYCHIATRY | GUILLAIN-BARRE-SYNDROME | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL NEUROLOGY | HIV-INFECTED PATIENTS | UNINFECTED CHILDREN BORN | REVERSE-TRANSCRIPTASE INHIBITORS | PHARMACOLOGY & PHARMACY | HEREDITARY OPTIC NEUROPATHY | PLACEBO-CONTROLLED TRIAL | PERSISTENT MITOCHONDRIAL DYSFUNCTION | ZIDOVUDINE-INDUCED MYOPATHY | Peripheral Nervous System Diseases - diagnosis | Peripheral Nervous System Diseases - epidemiology | Anti-Retroviral Agents - therapeutic use | Neurotoxicity Syndromes - diagnosis | Peripheral Nervous System Diseases - chemically induced | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Humans | Anti-Retroviral Agents - adverse effects | Anti-Retroviral Agents - pharmacology | Peripheral Nervous System Diseases - enzymology | Treatment Outcome | Clinical Trials as Topic | Mental Disorders - psychology | Neurotoxicity Syndromes - etiology | Neurotoxicity Syndromes - enzymology | Mental Disorders - enzymology | Anti-Retroviral Agents - administration & dosage | DNA-Directed DNA Polymerase - metabolism | Neurotoxicity Syndromes - epidemiology | Stroke (Disease) | Antiviral agents | Complications and side effects | Insomnia | Analysis | Cytochrome P-450 | Risk factors | Antiretroviral drugs | Neurotoxicity | Pathogenesis | Toxicity | Medical treatment | Older people | Mortality | Suicides & suicide attempts | Clinical trials | Mitochondrial DNA | Drug dosages | Index Medicus
Journal Article
Journal Article
Journal Article
Toxicology Letters, ISSN 0378-4274, 11/2014, Volume 231, Issue 1, pp. 45 - 54
The highly toxic organophosphorus (OP) nerve agent VX is characterized by a remarkable biological persistence which limits the effectiveness of standard... 
Therapy | Bioscavenger | Phosphotriesterase | Nerve agents | Mutant | PROTECTION | VIVO | QUANTIFICATION | HUMAN BUTYRYLCHOLINESTERASE | TOXICITY | ORGANOPHOSPHORUS NERVE AGENTS | IN-VITRO | CYCLOSARIN | PRETREATMENT | SWINE BLOOD-SAMPLES | TOXICOLOGY | Cholinesterase Inhibitors - pharmacokinetics | Cholinesterase Inhibitors - toxicity | Chemical Warfare Agents - pharmacokinetics | Cholinesterase Inhibitors - blood | Brain - enzymology | Male | Antidotes - administration & dosage | Neurotoxicity Syndromes - drug therapy | Organothiophosphorus Compounds - toxicity | Organothiophosphorus Compounds - blood | Time Factors | Neurotoxicity Syndromes - blood | Protein Engineering | Catalysis | Erythrocytes - enzymology | Antidotes - metabolism | Acetylcholinesterase - blood | Guinea Pigs | Drug Administration Schedule | Phosphoric Triester Hydrolases - genetics | Phosphoric Triester Hydrolases - administration & dosage | Chemical Warfare Agents - metabolism | Recombinant Proteins - administration & dosage | Erythrocytes - drug effects | Brain - drug effects | Hydrolysis | Neurotoxicity Syndromes - etiology | Neurotoxicity Syndromes - enzymology | Organothiophosphorus Compounds - pharmacokinetics | Animals | Phosphoric Triester Hydrolases - metabolism | Chemical Warfare Agents - toxicity | Mutation | Enantiomers | Nerve gas | Toxicology | Catalysts | Toxic | Toxicity | Biocompatibility | Intoxication | Blood
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 5262 - 10
Journal Article
Journal Article
Neurotoxicology, ISSN 0161-813X, 06/2012, Volume 33, Issue 3, pp. 314 - 320
► We examined toxic effects of PFOS on cerebellar granule cells (CGC) from SD rats. ► PFOS increased ROS production and selectively translocated PKC isozymes.... 
Protein kinase C | Perfluorooctane sulfonate | Cerebellar granule cell | ROS | Apoptosis | NEONATAL EXPOSURE | ACID | SYNAPTOGENESIS | INVOLVEMENT | NEUROTOXICITY | NEUROSCIENCES | HIPPOCAMPUS | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | MICE | TOXICOLOGY | BRAIN | PFOS | Fluorocarbons - toxicity | Neurons - pathology | Protein Kinase C - genetics | Reactive Oxygen Species - metabolism | Neurotoxicity Syndromes - genetics | Apoptosis - drug effects | Caspase 3 - metabolism | Cerebellum - drug effects | Cerebellum - enzymology | Dose-Response Relationship, Drug | Transfection | Neurotoxicity Syndromes - pathology | RNA Interference | Protein Kinase C - metabolism | DNA Fragmentation | Neurons - drug effects | In Situ Nick-End Labeling | Cell Survival - drug effects | Isoenzymes | Cells, Cultured | Rats | Neurotoxicity Syndromes - prevention & control | Antioxidants - pharmacology | Rats, Sprague-Dawley | Cerebellum - pathology | Protein Transport | Neurotoxicity Syndromes - etiology | Neurotoxicity Syndromes - enzymology | Animals | Signal Transduction - drug effects | Neurons - enzymology | Alkanesulfonic Acids - toxicity | Enzyme Activation | Oxidative Stress - drug effects | Brain | Surface active agents | Protein kinases | Index Medicus | Cerebellum | Translocation | Cell culture | Reactive oxygen species | Granule cells | Memory | Motor activity | Consumers | Acetylcysteine | siRNA | Caspase-3 | Learning | Signal transduction | Neurotoxicity | DNA fragmentation
Journal Article